Biogen Investors: Active Ingredient In Patient Death Is Not Changing BofA's Forecast
April 09, 2015 at 12:20 PM EDT
Bank of America commented on Biogen Inc (NASDAQ: BIIB) Wednesday following the death of a patient due to fatal progressive multifocal ...